Daily cannabis news and breaking stories from markets, policy, and medical sectors worldwide.
Grow Group has announced the completion of a recapitalisation, has appointed Co-CEOs, and now expects to generate healthy EBITDA in 2027.
UK medical cannabis patients have been told that they’ll have access to a six-month stockpile of Bedrolite, following weeks of uncertainty in the wake of Bedrocan’s collapse.
A Michigan cultivator is fighting to overturn a landmark court decision which has thrown the enforceability of cannabis industry contracts across the US into question.
UK medical cannabis cultivator Glass Pharms has partnered with leading clinic Releaf to bring cannabis containing meaningful levels of THCV (Tetrahydrocannabivarin), a cannabinoid linked to reduced appetite in emerging research, to patients in the UK for the first time since 1973.
Spain’s medical cannabis framework will finally start reaching patients over the coming days and weeks, marking a significant milestone in a four-year battle for access.
Helius Therapeutics has today announced a supply agreement with the University of Auckland for a new Phase 2 trial into cannabis as a sleep aid for patients which chronic back pain.
Frances’ incoming medical cannabis framework is expected to take the final step before it can be signed into law in the ‘coming weeks’.
The UK’s Cannabis Industry Council (CIC) has launched a new report calling for industrial hemp regulation to be transferred from the Home Office to the Department for Environment, Food and Rural Affairs (DEFRA), arguing that the current licensing regime is holding back a crop capable of helping the UK meet its binding Net Zero commitments.
Bedrocan’s Dutch entities have officially been declared bankrupt, leaving stocks of life-saving medicinal cannabis in the hands of court-appointed administrators who cannot release them.
